Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
1997 | 1 |
2021 | 1 |
2023 | 1 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Page 1
Effect of Alteplase on Ischemic Stroke Mortality Is Dependent on Stroke Severity.
Ann Neurol. 2023 Jun;93(6):1106-1116. doi: 10.1002/ana.26621. Epub 2023 Mar 17.
Ann Neurol. 2023.
PMID: 36852919
OBJECTIVE: Although intravenous alteplase (IV-tPA) has a beneficial effect on functional outcome after ischemic stroke (IS), prior studies of IV-tPA's impact on post-stroke mortality did not have sufficient representation of more severe stroke. METHODS: We determine …
OBJECTIVE: Although intravenous alteplase (IV-tPA) has a beneficial effect on functional outcome after ischemic stroke (IS), prior st …
Changes in Mode of Oxygen Delivery and Physiological Parameters with Physiotherapy in COVID-19 Patients: A Retrospective Study.
Verma CV, Arora RD, Mistry HM, Kubal SV, Kolwankar NS, Patil PC, Dalvi AA, Vichare SA, Natesan A, Mangaonkar AN, Kanakia DD, Jere GS, Bansode KY, Patil MR, Sheth RD, Dudhavade SD, Mhatre SD, Patel SK, Mohite AG, Bhavsar AN, Alfonso JE, Syed MN, Savla NP, Rajgond RN, Bute RA, Mane SM, Jaiswal SR, Parab VA, Kasbe AM, Joshi MA, Bharmal RN.
Verma CV, et al.
Indian J Crit Care Med. 2021 Mar;25(3):317-321. doi: 10.5005/jp-journals-10071-23763.
Indian J Crit Care Med. 2021.
PMID: 33790514
Free PMC article.
Its severity ranges from mild to severe, latter manifesting into severe acute respiratory syndrome. As a part of multidisciplinary team, physiotherapy along with medical management was administered to patients with COVID-19 in an acute care setup. ...(i) Characteristics of …
Its severity ranges from mild to severe, latter manifesting into severe acute respiratory syndrome. As a part of multidisciplinary te …
Item in Clipboard
Pulmonary embolism developing in patients with sickle cell disease on hypertransfusion and IV deferoxamine chelation therapy.
Sheth S, Ruzal-Shapiro C, Hurlet-Jensen A, Piomelli S, Berdon WE.
Sheth S, et al.
Pediatr Radiol. 1997 Dec;27(12):926-8. doi: 10.1007/s002470050273.
Pediatr Radiol. 1997.
PMID: 9388284
Pulmonary disease, including thromboembolic problems, accounts for a large portion of the morbidity of sickle cell disease. Chronic transfusion therapy is now a part of long-term treatment of sickle cell patients with stroke and chest syndrome. ...
Pulmonary disease, including thromboembolic problems, accounts for a large portion of the morbidity of sickle cell disease. Chronic transfus …
Item in Clipboard
Cite
Cite